MAGEA12 and breast carcinoma: Moreover, the fact that histone modifications at the MAGEA12 locus correlated strongly with MAGEA12 expression levels suggests that both the expression levels of MAGEA12 and the unique characteristics of the histone markers at its locus have potential as biomarkers for classifying breast cancer cells.